C3M3
C3M3 is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2024 annual accounts show equity of €359k and a net result of €-153k. Equity is shrinking by ~27.5% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2027. Its solvency ranks better than 25% of 768 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €359k |
| Net result | €-153k |
| Better than sector | 25% |
| Active | 4 yrs |
Fragile profile, watch profitability in particular.
Computed on 4 of 5 axes. Not measured: health. An unmeasured axis is not a zero: no data was read for it.
This is a financial institution (bank, insurer or financial holding). Our bankruptcy model is trained on ordinary trading and manufacturing companies; a bank balance sheet falls outside that scope. We therefore show no bankruptcy probability rather than a misleading figure.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 12.5% | 38.7% | |
| Net result | €-153k | €28k | |
| Equity | €359k | €63k | |
| Gross operating margin | €6k | €67k | |
| Total assets | €2.88M | €190k |
| Fiscal year | 2024 |
|---|---|
| Deposit | micro |
| Revenue | n/a |
| EBITDA | n/a |
| Net profit | €-153k |
| Cash flow | n/a |
| Staff costs | - |
| Income taxes | €105 |
| Dividends | - |
| Total assets | €2.88M |
| Equity | €359k |
| Debt | €2.52M |
| of which ≤ 1y | €1.88M |
| of which > 1y | €637k |
| Working capital | n/a |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | n/a |
| Quick ratio | n/a |
| Working capital ratio | n/a |
| Solvency | 12.5% |
| Debt / equity | n/a |
| Long-term debt ratio | n/a |
| Interest coverage | n/a |
| Gross margin | n/a |
| Net margin | n/a |
| ROA | -5.3% |
| ROE | -42.6% |
| EBITDA margin | n/a |
| Days sales outstanding | n/a |
| Days payable outstanding | n/a |
| Inventory turnover | n/a |
| Days inventory (DSI) | n/a |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €2.88M |
| Fixed assets | 21/28 | €2.87M |
| Tangible fixed assets | 22/27 | €2.87M |
| Current assets | 29/58 | €6k |
| Cash & bank | 54/58 | €5k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €2.88M |
| Equity | 10/15 | €359k |
| Contributions / capital | 10/11 | €1.00M |
| Accumulated profits (losses) | 14 | €-641k |
| Amounts payable | 17/49 | €2.52M |
| Amounts payable after one year | 17 | €637k |
| Amounts payable within one year | 42/48 | €1.88M |
| Trade debts payable within one year | 44 | €5k |
| Income statement | ||
| Gross operating margin | 9900 | €6k |
| Operating result | 9901 | €-114k |
| Financial charges | 65 | €39k |
| Result before taxes | 9903 | €-153k |
| Income taxes | 67/77 | €105 |
| Net result for the period | 9904 | €-153k |
| Result to be appropriated | 9905 | €-153k |
-
CLINIMETRICS S.A.Legal entityDirector· perm. rep.: Marc BUYSEState Gazette act 25094025 (23-07-2025)Current01-04-2025 → present
2 events
- 01-04-2025 Resigned· Director
- 01-04-2025 Appointed· Director
-
S.R.L. NITYALegal entityDirector· perm. rep.: Céline BUYSEState Gazette act 25094025 (23-07-2025)Current01-04-2025 → present
2 events
- 01-04-2025 Resigned· Director
- 01-04-2025 Appointed· Director
| NACE primary | 66300 |
| Legal form | Private limited company(610) |
| Incorporation | 27-01-2022 |
| Status | Active |
| Postal code | 1180 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25033C0433/00A000 | Wallonia | 909 m² | 1 · 142 m² | 11.0 m · 2 fl. |
| 21612C0294/00D019 | Brussels | 884 m² | 1 · 170 m² | 16.4 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
23-12-2025 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"notary": {
"name": "Beno\u00EEt HEYMANS",
"firm_city": null,
"firm_name": null,
"office_city": "Uccle",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2025-12-23",
"filing_date": "2025-12-19",
"act_kind_objet": "DIVERS"
},
"key_dates": [
{
"date": "2025-12-18",
"label": "date de l\u0027acte"
},
{
"date": "2022-01-27",
"label": "date de constitution de la soci\u00E9t\u00E9"
},
{
"date": "2025-12-15",
"label": "date de r\u00E9ception du projet"
},
{
"date": "2025-12-15",
"label": "date de l\u0027attestation de l\u0027organisme d\u00E9positaire"
}
],
"key_parties": [
{
"kind": "person",
"name": "C\u00E9line BUYSE",
"role": "administrateur"
},
{
"kbo": "045489288",
"kind": "org",
"name": "HETAFIN",
"role": "actionnaire"
},
{
"kind": "person",
"name": "Henri TASSENOY",
"role": "repr\u00E9sentant"
},
{
"kind": "person",
"name": "Beno\u00EEt HEYMANS",
"role": "Notaire instrumentaire"
}
],
"key_amounts_eur": [
{
"label": "montant des apports en num\u00E9raire",
"amount": 2500000.0
},
{
"label": "capitaux propres disponibles",
"amount": 3500000.0
},
{
"label": "droit d\u0027\u00E9criture",
"amount": 100.0
}
],
"subject_company": {
"kbo": "0780.999.260",
"name_full": "C3M3",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
},
"publication_proxy": {
"kind": null
},
"summary_narrative": "",
"co_filed_documents": [],
"detected_real_type": "capital_increase"
}23-07-2025 Registered office moved from Genval to Uccle
- Centenaire cinquième avenue 5, 1332 Genval → Chaussée de Waterloo 1139, 1180 Uccle
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Uccle",
"region": "Brussels",
"street": "Chauss\u00E9e de Waterloo",
"country": "BE",
"postcode": "1180",
"box_number": null,
"street_number": "1139"
},
"old_address": {
"city": "Genval",
"region": "Brussels",
"street": "Centenaire cinqui\u00E8me avenue",
"country": "BE",
"postcode": "1332",
"box_number": null,
"street_number": "5"
},
"effective_date": "2025-05-01",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire du 1er mai 2025 a d\u00E9cid\u00E9 \u00E0 l\u0027unanimit\u00E9 de transf\u00E9rer le si\u00E8ge \u00E0 partir du 1er mai 2025 chauss\u00E9e de Waterloo 1139 \u00E0 1180 Uccle."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0780.999.260",
"name_full": "C3M3",
"legal_form": "SRL"
}
}31-01-2022 Incorporation of a new SRL
Technical details
{
"kind": "oprichting",
"seat": "1332 Rixensart (Genval), Centenaire 5e avenue 5",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": null,
"name": "CLINIMETRICS"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": "CLINIMETRICS",
"contribution_type": "cash",
"amount_paid_in_eur": 1000000,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 10000,
"amount_subscribed_eur": 1000000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 1000000,
"subject_company": {
"kbo": "0780.999.260",
"name_full": "C3M3",
"legal_form": "SRL"
},
"initial_directors": [],
"incorporation_date": "2022-01-27",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | C3M3 |